Advanced SearchSearch Tips
5-Aminolevulinic Acid Fluorescence in Detection of Peritoneal Metastases
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
5-Aminolevulinic Acid Fluorescence in Detection of Peritoneal Metastases
Yonemura, Yutaka; Canbay, Emel; Ishibashi, Haruaki; Nishino, Eisei; Endou, Yoshio; Sako, Shouzou; Ogura, Shun-Ichirou;
  PDF(new window)
Background: The value of 5-aminolevulinic acid (ALA) in fluorescence detection of peritoneal metastases and the underlying mechanisms were evaluated in patients with peritoneal surface malignancies. Materials and Methods: Oral 5-ALA was administered at a concentration of 20 mg/kg body weight with 50 ml of water 2 hours prior to surgery (n
Aminolevulinic acid;photodynamic diagnosis;peritoneal surface malignancies;PEPT1;ABCG2;
 Cited by
Image-guided surgery in gynecologic oncology, Future Oncology, 2017, 13, 26, 2321  crossref(new windwow)
Photodynamic Detection of Peritoneal Metastases Using 5-Aminolevulinic Acid (ALA), Cancers, 2017, 9, 3, 23  crossref(new windwow)
Ahmad S, Aboumarzouk O, Somani B, et al (2015). . Oral 5-aminolevulinic acid in simultaneous photodynamic diagnosis of upper and lower urinary tract transitional cell carcinoma - a prospective audit. BJU Int, 110, 596-600

Almerie MQ, Gossedge G, Wright KE, et al (2015). . Photodynamic diagnosis for detection of peritoneal carcinomatosis. J Surg Res, 195, 175-87 crossref(new window)

Canbay E, Ishibashi H, Sako S, et al (2014). Photodynamic detection and management of intraperitoneal spreading of primary peritoneal papillary serous carcinoma in a man: report of a case. Surg Today, 44, 373-7 crossref(new window)

Canis M, Botchorishvili R, Berreni N, et al (2001). 5-Aminolevulinic acid-induced (ALA). fluorescence for the laparoscopic diagnosis of peritoneal metastasis. AST An experimental study. Surg Endosc, 15, 1184-6 crossref(new window)

Chu DZ, Lang NP, Thompson C, et al (2004). Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer, 63, 364-7

Chua TC, Moran BJ, Sugarbaker PH, et al (2012). Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol, 30, 2449-56 crossref(new window)

Daniltchenko DI, Riedl CR, Sachs MD, et al (2005). Longterm benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study. J Urol, 174, 2129-33 crossref(new window)

Denzinger S, Burger M, Walter B, et al (2007). Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8- year results of prospective randomized study. Urol, 69, 675-9 crossref(new window)

Glehen O, Cotte E, Schreiber V, et al (2004). Intraperitoneal chemohyperthermia and attempted cytoreductive surgery in patients with peritoneal carcinomatosis of colorectal origin. Br J Surg, 91,747-54 crossref(new window)

Glehen O, Gilly FN, Arvieux C, et al (2010). Association Francaise de Chirurgie Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Ann Surg Oncol, 17, 2370-7 crossref(new window)

Hagiya Y, Adachi T, Ogura S, An R, et al (2008). Nrf2- dependent induction of human ABC transporter ABCG2 and heme oxygenase-1 in HepG2 cells by photoactivation of porphyrins: biochemical implicationsfor cancer cell response to photodynamic therapy. J ExpTher Oncol, 7, 153-67

Hagiya Y, Endo Y, Yonemura Y, et al (2012). Pivotal roles of peptide transporter PEPT1 and ATP-binding cassette (ABC). transporter ABCG2 in 5-aminolevulinic acid (ALA). -based photocytotoxicity of gastric cancer cells in vitro. Photodiagnosis Photodynamic Therapy, 9, 204-14. crossref(new window)

Jayne DG, Fook S, Loi C, et al (2002). Peritoneal carcinomatosis from colorectal cancer. Br J Surg, 89,1545-50 crossref(new window)

Kishi K, Fujiwara Y, Yano M, et al (2012). Staging laparoscopy using ALA-mediated photodynamic diagnosis improves the detection of peritoneal metastases in advanced gastric cancer. J Surg Oncol, 106, 294-8 crossref(new window)

Krammer B and Plaetzer K. (2008). ALA and its clinical impact, from bench to bedside. Photochem Photobiol Sci, 7, 283-9 crossref(new window)

Ladner DP, Steiner RA, Allemann J, et al (2001). Photodynamic diagnosis of breast tumors after oral application of aminolevulinic acid. Br J Cancer, 84, 33-7 crossref(new window)

Loning M, Diddens H, Kupker W, et al (2004). Laparoscopic fluorescence detection of ovarian carcinoma metastases using 5-aminolevulinic acid-induced protoporphyrin IX. Cancer, 100, 1650-6 crossref(new window)

Orth K, Russ D, Steiner R, et al (2000). Fluorescence detection of small gastrointestinal tumours: Principles, technique, first clinical experience. Langenbecks Arch Surg, 385,488-94 crossref(new window)

Sadeghi B, Arvieux C, Glehen O, et al (2000). Peritoneal carcinomatosis from non- gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer, 88, 358-63. crossref(new window)

Stummer W, Pichlmeier U, Meinel T, et al (2006). ALAGlioma Study Group. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol, 7, 392-401 crossref(new window)

Sugarbaker PH, Cunliffe WJ, Belliveau J, et al (1989). Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer. Semin Oncol, 16, 83-97

Sugarbaker PH (1998). Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis. Semin Surg Oncol, 14, 254-61 crossref(new window)

Sugarbaker PH (2006). New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol, 7, 69-76 crossref(new window)

Verwaal VJ, Bruin S, Boot H, et al (2008). 8-year followup of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol, 15, 2426-32 crossref(new window)

Yan TD, Brun EA, Cerruto CA, et al (2007). Prognostic indicators for patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma. Ann Surg Oncol, 14, 41-9

Yan TD, Deraco M, Baratti D, et al(2009). Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peri toneal mesothelioma: multi-institutional experience. J Clin Oncol, 27, 6237-42 crossref(new window)

Yang XJ, Huang CQ, Suo T, et al (2011). Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Ann Surg Oncol, 18, 1575-81 crossref(new window)

Zopf T, Schneider AR, Weickert U, et al (2005). Improved preoperative tumor staging by 5-aminolevulinic acid induced fluorescence laparoscopy. Gastrointest Endosc, 62,763-7 crossref(new window)